Kerry Breen is a news editor at CBSNews.com. A graduate of New York University's Arthur L. Carter School of Journalism, she previously worked at NBC News' TODAY Digital. She covers current events, ...

CHICAGO — Patients who develop acute pancreatitis while being treated with GLP-1 receptor agonists (RAs) show lower rates of recurrence if they continue with the treatment than if they discontinue, ...

Get unlimited access to ad-free articles and exclusive content. An AI model developed at the Mayo Clinic in Rochester, Minnesota, detected abnormalities on patients’ CT scans up to three years before ...

Ben Sasse says he’s still alive thanks to "providence, prayer and a miracle drug." The 54-year-old former U.S. senator from Nebraska was told he had four months to live at most last December when he ...

Former Republican Sen. Ben Sasse is crediting a "miracle drug" currently under review by the Food and Drug Administration for helping him manage his pancreatic cancer, a diagnosis he announced in ...

New clinical trial data show KRAS-blocking drugs may significantly improve survival for the disease. “I think this is truly an earth-shattering moment in pancreatic cancer.” Daraxonrasib, an ...

After decades of struggling to find a way to treat pancreatic cancer, researchers have developed several promising new drugs that could offer rare hope to patients given this particularly deadly ...

SAN DIEGO — Experimental therapies with radically different approaches are stirring a wave of optimism that survival rates could substantially improve for pancreatic cancer, one of the most stubbornly ...

Pancreatic cancer is one of the deadliest cancers. It killed nearly 52,000 Americans last year, many within a year of diagnosis. Now, there are some new experimental medicines with the potential to ...

When former Nebraska Sen. Ben Sasse was diagnosed with Stage 4 pancreatic cancer in December, he was given three to four months to live. Now a drug by Revolution Medicines is giving him precious more ...

Angus reports on the basic research, clinical science, and drug development that may transform survival and quality of life for patients, as well as developments affecting the cancer community. You ...